Intelligence · Patents

Patents expiring in 2027

Annual patent cliff calendar for 2027 — US pharmaceutical patents by expiration date.

Patents
578

Quick answer

578 indexed pharmaceutical patents have expiration dates in 2027. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 7161003

    Pyrazolopyrimidines as cyclin dependent kinase inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 7160887

    Aromatic amine derivatives, their production and use

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 7160868

    Nr-CAM gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors

    Northwest Hospital · Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 7160726

    Compositions comprising conditioned cell culture media and uses thereof

    SkinMedica, Inc. · Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 7160375

    Aqueous glittering color material composition

    SAKURA COLOR PRODUCTS CORPORATION · Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 7161059

    Human hookworm model and method for maintaining human hookworm in a non-human primate

    The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and Northern Ireland · Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 7160722

    Master bone formation transcription factor: compositions and methods of use

    The Board of Regents of the University of Texas System · Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 7160867

    Rapamycin carbohydrate derivatives

    Isotechnika, Inc. · Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 7160984

    Process for preparing glycopeptide derivatives

    Theravance, Inc. · Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 7161012

    Processes for preparing amorphous atorvastatin hemi-calcium

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 7160720

    CHAMP—a novel cardiac helicase-like factor

    The Board of Regents of the University of Texas System · Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 7163925

    p16 expression constructs and their application in cancer therapy

    The Board of Regents of the University of Texas System · Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 7163673

    Sunscreen reagents from hydroxy-substituted acylglycerides

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 7164000

    RANTES mutants and therapeutic applications thereof

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 7163678

    Reovirus for the treatment of ral-mediated cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 7163946

    5-substituted 7,9-difluoro-5H-chromeno[3,4-f]quinoline compounds as selective progesterone receptor modulator compounds

    Ligand Pharmaceuticals Incorporated · Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 7163935

    Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 7163824

    Regulation of endogenous gene expression in cells using zinc finger proteins

    Sangamo Biosciences, Inc. · Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 7163818

    Bacteriophage having multiple host range

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 7163934

    Methods for treating delirium glucocorticoid receptor-specific antagonists

    Corcept Therapeutics Incorporated · Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 7163806

    Somatic cells with ablated PrP gene and methods of use

    The Regents of the University of California · Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 7163700

    Amorphous drug beads

    Capricorn Pharma Inc. · Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 7163686

    Protein A based binding domains with desirable activities

    The Regents of the University of California · Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 7166619

    Prenylation inhibitors and methods of their synthesis and use

    PPD Discovery, Inc. · Granted Tue Jan 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 7166721

    Preparation of 1H-imidazo[4,5-C] quinolin 4-amines via novel 1H-imidazo[4,5-c] quinolin 4-cyano and 1H-imidazo[4,5-c] quinolin 4-carboxamide intermediates

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Jan 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 7166588

    Derivatives and analogs of galanthamine

    SANOCHEMIA PHARMAZEUTIKA AG · Granted Tue Jan 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 7166584

    Cholesterol transport gene

    Xenon Genetics Inc. · Granted Tue Jan 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 7166450

    Hyaluronan synthase gene and uses thereof

    The Board of Regents of the University of Oklahoma · Granted Tue Jan 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 7166578

    Orally administered peptides synergize statin activity

    The Regents of the University of California · Granted Tue Jan 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 7166762

    Method of constructing heart failure model animal

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 7166704

    Antibodies immunologically specific for PD2, a protein that is amplified and overexpressed in pancreatic cancer

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jan 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 7169384

    Tumor suppressor CAR-1

    The Board of Regents of the University of Texas System · Granted Tue Jan 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 7169411

    Composition for delivery of biological agents and methods for the preparation thereof

    UNIVERSITY OF NEBRASKA BOARD OF REGENTS · Granted Tue Jan 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. US 7169779

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Tue Jan 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 7169801

    Histone deacetylase inhibitors

    Takeda San Diego, Inc. · Granted Tue Jan 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 7169800

    Imidazole compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Tue Jan 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 7169798

    Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Tue Jan 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 7169815

    3-methoxybenzyl thiourea derivatives and improved lipid compositions containing same

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jan 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 7169799

    Process for producing crystal

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  40. US 7169726

    Catalyst for isomerization of solid fischer-tropsch paraffins and method for its production

    KataLeuna GmbH Catalysts · Granted Tue Jan 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  41. US 7169594

    Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  42. US 7173005

    Insulin and IGF-1 receptor agonists and antagonists

    ANTYRA INC. · Granted Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  43. US 7173007

    Therapy for microbial infections

    The United States of America as represented by the Department of Veteran Affairs · Granted Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  44. US 7172768

    Storage stable powder compositions of interleukin-4 receptor

    Nektar Therapeutics · Granted Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  45. US 7173027

    Receptor selective cannabimimetic aminoalkylindoles

    UNIVERSITY OF CONNECTICUT · Granted Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  46. US 7173062

    Method for the improvement of skin wrinkles using retinyl retinoate

    ENPRANI CO., LTD. · Granted Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  47. US 7172876

    Method of screening therapeutic agents for nerve degeneration associated diseases

    Takeda Pharmaceutical Company Limited · Granted Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  48. US 7172770

    Mesoporous compositions for use in drug delivery

    The Board of Regents of the University of Texas System · Granted Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2027?

578 published patents in our USPTO index have expiration dates falling in calendar year 2027.